BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers

  April 28, 2026

   · 

  8 min read
• Press Releases

  Avenzo Therapeutics Advances the Combination of CDK4 Selective Inhibitor (AVZO-023) with CDK2 Selective Inhibitor (AVZO-021) in Ongoing Phase 1/2 ORION-1 Study in HR+/HER2- Breast Cancer

  April 28, 2026

   · 

  3 min read
• Press Releases

  CorVista Health Announces Collaboration with Mayo Clinic to Advance Next-Gen Pulmonary Hypertension Diagnosis

  April 28, 2026

   · 

  3 min read
• Press Releases

  Thermo Fisher Scientific to Host Investor Day - April 28, 2026

  April 28, 2026

   · 

  1 min read
• Press Releases

  bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment

  April 28, 2026

   · 

  6 min read
• Press Releases

  AOP Health US Marks First Patient Treated with Rapiblyk® in the United States, Expanding Access to Critical Care Innovation Nationwide

  April 28, 2026

   · 

  5 min read
• Press Releases

  Sapient Launches Tumor Protein Mapping Platform to Characterize Functional Biology Across Critical Dimensions in Human Tumors

  April 28, 2026

   · 

  4 min read
• Press Releases

  CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs

  April 28, 2026

   · 

  6 min read
• Press Releases

  Dubai’s Medcare Hospital Becomes the World’s First to Treat an Adult Spinal Muscular Atrophy (SMA) Patient Outside the US

  April 28, 2026

   · 

  2 min read
• Press Releases

  IGC Pharma Advances Caregiver Engagement as Phase 2 CALMA Trial Advances Final Enrollment Phase

  April 28, 2026

   · 

  3 min read